Registry Study of Revcovi Treatment in Patients With ADA-SCID
Summary
- Eligibility
- for people ages 0 months to 65 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Morna Dorsey, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Morna Dorsey, MD
My research interests lie in three main focus areas: 1. Optimizing diagnosis and care of patients with primary immunodeficiency 2. Investigating the psychosocial impact of primary immunodeficiency on patients and families 3. Establishing treatment for patients with food allergy and eosinophilic disorders
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Chiesi Farmaceutici S.p.A.
- ID
- NCT03878069
- Study Type
- Observational [Patient Registry]
- Participants
- Expecting 34 study participants
- Last Updated